ChAdOx1-MVA 5T4 vaccine

N/A

Report date: 2025/07/29 17:48:07

Base Information

Drug NameChAdOx1-MVA 5T4 vaccine
Drug Alias NameChAdOx1-MVA 5T4VTP-800VTP-850
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsProstate-specific antigen modulatorsSix-transmembrane epithelial antigen of the prostate 1modulators +[5] 
TargetsProstate-specific antigenSix-transmembrane epithelial antigen of the prostate 1Trophoblast glycoprotein +[4] 
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsYes MVA.h5T4ChAdOx1.5T4
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of OxfordBarinthus Biotherapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBarinthus Biotherapeutics PLCUniversity Of Oxford
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A